Literature DB >> 19885260

The benefits of continuous glucose monitoring and a glucose monitoring schedule in individuals with type 1 diabetes during recreational diving.

Peter Adolfsson1, Hans Ornhagen, Johan Jendle.   

Abstract

BACKGROUND: Our objective is to evaluate the Medtronic CGMS continuous glucose monitoring system and plasma glucose (PG) measurement performed in a monitoring schedule as tools to identify individuals with type 1 diabetes at risk when diving.
METHODS: We studied 24 adults, 12 type 1 diabetes subjects and 12 controls, during 5 recreational scuba dives performed on 3 consecutive days. The CGMS was used by all participants on all the days and all the dives. Comparisons were made between PG performed in a monitoring schedule during the days of diving, self-monitored blood glucose (SMBG) performed 2 weeks prior to diving, and the CGMS during the study.
RESULTS: One hundred seventeen dives were performed. Hypoglycemia (<70 mg/dl) was found in six individuals and on nine occasions. However, no symptoms of hypoglycemia were present during or immediately postdiving. In one case, repetitive hypoglycemia prediving gave rise to a decision not to dive. None of the dives were aborted. The number of hypoglycemic episodes, 10 min prediving or immediately postdiving, were related to the duration of diabetes, r = 0.83 and p =0.01, and the percentage of SMBG values below target (<72 mg/dl), r = 0.65 and p =0.02. Moreover, the number of hypoglycemic episodes was also related to the total duration below low limit (<70 mg/dl), measured by the CGMS, r =0.74 and p =0.006.
CONCLUSION: Safe dives are possible to achieve by well-informed, well-controlled individuals with type 1 diabetes. Using downloaded SMBG, CGMS, and repetitive PG in a monitoring schedule, it is possible to identify those subjects who are suitable for diving.

Entities:  

Keywords:  CGMS; blood glucose; diving; type 1 diabetes mellitus

Year:  2008        PMID: 19885260      PMCID: PMC2769802          DOI: 10.1177/193229680800200505

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  9 in total

1.  IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.

Authors:  Wieland Hoelzel; Cas Weykamp; Jan-Olof Jeppsson; Kor Miedema; John R Barr; Ian Goodall; Tadao Hoshino; W Garry John; Uwe Kobold; Randie Little; Andrea Mosca; Pierluigi Mauri; Rita Paroni; Fransiscus Susanto; Izumu Takei; Linda Thienpont; Masao Umemoto; Hsiao-Mei Wiedmeyer
Journal:  Clin Chem       Date:  2004-01       Impact factor: 8.327

2.  Physiological differences between interstitial glucose and blood glucose measured in human subjects.

Authors:  Eray Kulcu; Janet A Tamada; Gerard Reach; Russell O Potts; Matthew J Lesho
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

3.  [Standards for long-term measures of blood sugar are established].

Authors:  H Arnqvist; M Wallensteen; J O Jeppson
Journal:  Lakartidningen       Date:  1997-12-10

4.  Scuba diving with diabetes mellitus--the UK experience 1991-2001.

Authors:  C J Edge; M St Leger Dowse; P Bryson
Journal:  Undersea Hyperb Med       Date:  2005 Jan-Feb       Impact factor: 0.698

5.  The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control.

Authors:  Ana Chico; Pablo Vidal-Ríos; Montserrat Subirà; Anna Novials
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

6.  Plasma glucose responses in recreational divers with insulin-requiring diabetes.

Authors:  G de L Dear; N W Pollock; D M Uguccioni; J Dovenbarger; M N Feinglos; R E Moon
Journal:  Undersea Hyperb Med       Date:  2004       Impact factor: 0.698

7.  Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring.

Authors:  B Aussedat; M Dupire-Angel; R Gifford; J C Klein; G S Wilson; G Reach
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-04       Impact factor: 4.310

8.  Prediction of severe hypoglycemia.

Authors:  Daniel J Cox; Linda Gonder-Frederick; Lee Ritterband; William Clarke; Boris P Kovatchev
Journal:  Diabetes Care       Date:  2007-03-15       Impact factor: 19.112

9.  Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes.

Authors:  Pietro Galassetti; Donna Tate; Ray A Neill; Sachiko Morrey; David H Wasserman; Stephen N Davis
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

  9 in total
  6 in total

1.  Continuous Glucose Monitoring Diving and Diabetes: An Update of the Swedish Recommendations.

Authors:  Johan Jendle; Peter Adolfsson
Journal:  J Diabetes Sci Technol       Date:  2019-02-02

2.  The current use of wearable sensors to enhance safety and performance in breath-hold diving: A systematic review.

Authors:  Giovanni Vinetti; Nicola F Lopomo; Anna Taboni; Nazzareno Fagoni; Guido Ferretti
Journal:  Diving Hyperb Med       Date:  2020-03-31       Impact factor: 0.887

Review 3.  Recreational diving in persons with type 1 and type 2 diabetes: Advancing capabilities and recommendations.

Authors:  Johan H Jendle; Peter Adolfsson; Neal W Pollock
Journal:  Diving Hyperb Med       Date:  2020-06-30       Impact factor: 0.887

Review 4.  Exercise and glucose metabolism in persons with diabetes mellitus: perspectives on the role for continuous glucose monitoring.

Authors:  Michael Riddell; Bruce A Perkins
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

5.  In-vitro performance of the Enlite Sensor in various glucose concentrations during hypobaric and hyperbaric conditions.

Authors:  Peter Adolfsson; Hans Ornhagen; Bengt M Eriksson; Raghavendhar Gautham; Johan Jendle
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

6.  Comparison of venous, capillary and interstitial blood glucose data measured during hyperbaric oxygen treatment from patients with diabetes mellitus.

Authors:  Carol Baines; Don Vicendese; David Cooper; William McGuiness; Charne Miller
Journal:  Diving Hyperb Med       Date:  2021-09-30       Impact factor: 1.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.